ARCHIVES

NCI Advisors Approve Plans To Continue Current Research Programs.

This article is from The Cancer Letter archive.

Vol. 34 No. 26 | July 3, 2008

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

Computer Interpretation Software Does Not Improve Detection

August 26, 2011